Centro Estudios Moleculares de la Celula, Departamento de Bioquimica y Biología Molecular, Facultad de Ciencias Quimicas y Farmaceuticas and Facultad de Medicina, Universidad de Chile, Santiago, Chile.
Cell Death Dis. 2011 Dec 22;2(12):e244. doi: 10.1038/cddis.2011.130.
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide. Although treatments have improved, development of novel therapies for patients with CVD remains a major research goal. Apoptosis, necrosis, and autophagy occur in cardiac myocytes, and both gradual and acute cell death are hallmarks of cardiac pathology, including heart failure, myocardial infarction, and ischemia/reperfusion. Pharmacological and genetic inhibition of autophagy, apoptosis, or necrosis diminishes infarct size and improves cardiac function in these disorders. Here, we review recent progress in the fields of autophagy, apoptosis, and necrosis. In addition, we highlight the involvement of these mechanisms in cardiac pathology and discuss potential translational implications.
心血管疾病(CVD)是全球发病率和死亡率的主要原因。尽管治疗方法有所改善,但开发针对 CVD 患者的新型治疗方法仍然是一个主要的研究目标。细胞凋亡、坏死和自噬发生在心肌细胞中,慢性和急性细胞死亡是包括心力衰竭、心肌梗死和缺血/再灌注在内的心脏病理学的特征。自噬、细胞凋亡或坏死的药理学和遗传学抑制可减少这些疾病中的梗塞面积并改善心脏功能。在这里,我们回顾了自噬、细胞凋亡和坏死领域的最新进展。此外,我们强调了这些机制在心脏病理学中的参与,并讨论了潜在的转化意义。